Darlene Noci - Feb 2, 2023 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Development Officer
Signature
/s/ Deborah A. Miller, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Feb 2, 2023
Transactions value $
-$85,427
Form type
4
Date filed
2/3/2023, 03:45 PM
Previous filing
Jan 6, 2023
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $3.24K +3K $1.08* 3K Feb 2, 2023 Direct F1
transaction NUVL Class A Common Stock Sale -$58.4K -1.99K -66.27% $29.37 1.01K Feb 2, 2023 Direct F1, F2
transaction NUVL Class A Common Stock Sale -$30.3K -1.01K -100% $29.92 0 Feb 2, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -3K -2.43% $0.00 120K Feb 2, 2023 Class A Common Stock 3K $1.08 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2022.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.83 to $29.82, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.83 to $30.04, inclusive.
F4 The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder have vested or shall vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.